Retraction: "Nuclear extracellular signal-regulated kinase 1 and 2 translocation is mediated by casein kinase 2 and accelerated by autophosphorylation" [Molecular and Cellular Biology, 31, 17, (2011) (3515-3530)] doi: 10.1128/MCB.05424-11;Nuclear extracellular signal-regulated kinase 1 and 2 translocation is mediated by casein kinase 2 and accelerated by autophosphorylation

Molecular and Cellular Biology

Volumn 31, Issue 17, 2011, Pages 3515-3530

  Plotnikov, Alexander ^a   Chuderland, Dana ^a   Karamansha, Yael ^b   Livnah, Oded ^b   Seger, Rony ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CYTOPLASM PROTEIN; KARYOPHERIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPHOSPHORYLATION; CRYSTAL STRUCTURE; EMBRYO; ENZYME ACTIVITY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; NUCLEAR TRANSLOCATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 80052332583     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00106-18     Document Type: Erratum

References (53)

1. Bodart, J. F. 2010. Extracellular-regulated kinase-mitogen-activated protein kinase cascade: unsolved issues. J. Cell. Biochem. 109:850-857.
2. Brunet, A., et al. 1999. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18:664-674.
3. Burgermeister, E., et al. 2007. Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma. Mol. Cell. Biol. 27:803-817.
4. Calvo, F., L. Agudo-Ibanez, and P. Crespo. 2010. The Ras-ERK pathway: understanding site-specific signaling provides hope of new anti-tumor therapies. Bioessays 32:412-421.
5. Casar, B., A. Pinto, and P. Crespo. 2008. Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes. Mol. Cell 31:708-721.
6. Chuderland, D., A. Konson, and R. Seger. 2008. Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol. Cell 31:850-861.
7. Chuderland, D., and R. Seger. 2005. Protein-protein interactions in the regulation of the extracellular signal-regulated kinase. Mol. Biotechnol. 29: 57-74.
8. Duncan, J. S., and D. W. Litchfield. 2008. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim. Biophys. Acta 1784:33-47.
9. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132.
10. Formstecher, E., et al. 2001. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1:239-250.
11. Fukuda, M., Y. Gotoh, and E. Nishida. 1997. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J. 16:1901-1908.
12. Galli, S., et al. 2009. A new paradigm for MAPK: structural interactions of hERK1 with mitochondria in HeLa cells. PLoS One 4:e7541.
13. Gorlich, D. 1997. Nuclear protein import. Curr. Opin. Cell Biol. 9:412-419.
14. Hessenauer, A., C. C. Schneider, C. Gotz, and M. Montenarh. 2011. CK2 inhibition induces apoptosis via the ER stress response. Cell. Signal. 23:145-151.
15. Kim, E. K., and E. J. Choi. 2010. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 1802:396-405.
16. Kolch, W. 2005. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6:827-837.
17. Kolch, W., and A. Pitt. 2010. Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat. Rev. Cancer 10:618-629.
18. Kuenzel, E. A., J. A. Mulligan, J. Sommercorn, and E. G. Krebs. 1987. Substrate specificity determinants for casein kinase II as deduced from studies with synthetic peptides. J. Biol. Chem. 262:9136-9140.
19. Lamzin, V. S., and K. S. Wilson. 1993. Automated refinement of protein models. Acta Crystallogr. D Biol. Crystallogr. 49:129-147.
20. Litchfield, D. W. 2003. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369:1-15.
21. Lorenzen, J. A., et al. 2001. Nuclear import of activated D-ERK by DIM-7, an importin family member encoded by the gene moleskin. Development 128:1403-1414.
22. Meggio, F., and L. A. Pinna. 2003. One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17:349-368.
23. Murshudov, G. N., A. A. Vagin, and E. J. Dodson. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53:240-255.
24. Niefind, K., C. W. Yde, I. Ermakova, and O. G. Issinger. 2007. Evolved to be active: sulfate ions define substrate recognition sites of CK2alpha and emphasise its exceptional role within the CMGC family of eukaryotic protein kinases. J. Mol. Biol. 370:427-438.
25. Nigg, E. A. 1997. Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature 386:779-787.
26. Orlandini, M., et al. 1998. Protein kinase CK2alpha′ is induced by serum as a delayed early gene and cooperates with Ha-ras in fibroblast transformation. J. Biol. Chem. 273:21291-21297.
27. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
28. Pinna, L. A., and J. E. Allende. 2009. Protein kinase CK2 in health and disease: CK2: an ugly duckling in the kinome pond. Cell. Mol. Life Sci. 66:1795-1799.
29. Plotnikov, A., E. Zehorai, S. Procaccia, and R. Seger. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim. Biophys. Acta, in press.
30. Potterton, E., P. Briggs, M. Turkenburg, and E. Dodson. 2003. A graphical user interface to the CCP4 program suite. Acta Crystallogr. D 59:1131-1137.
31. Raman, M., W. Chen, and M. H. Cobb. 2007. Differential regulation and properties of MAPKs. Oncogene 26:3100-3112.
32. Reszka, A. A., J. C. Bulinski, E. G. Krebs, and E. H. Fischer. 1997. Mitogenactivated protein kinase/extracellular signal-regulated kinase 2 regulates cytoskeletal organization and chemotaxis via catalytic and microtubule-specific interactions. Mol. Biol. Cell 8:1219-1232.
33. Romieu-Mourez, R., E. Landesman-Bollag, D. C. Seldin, and G. E. Sonenshein. 2002. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res. 62:6770-6778.
34. Rubinfeld, H., T. Hanoch, and R. Seger. 1999. Identification of a cytoplasmic-retention sequence in ERK2. J. Biol. Chem. 274:30349-30352.
35. Ruzzene, M., and L. A. Pinna. 2010. Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim. Biophys. Acta 1804: 499-504.
36. Schwartz, D., and S. P. Gygi. 2005. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat. Biotechnol. 23:1391-1398.
37. Shaul, Y. D., G. Gibor, A. Plotnikov, and R. Seger. 2009. Specific phosphorylation and activation of ERK1c by MEK1b: a unique route in the ERK cascade. Genes Dev. 23:1779-1790.
38. Shaul, Y. D., and R. Seger. 2006. ERK1c regulates Golgi fragmentation during mitosis. J. Cell Biol. 172:885-897.
39. Shaul, Y. D., and R. Seger. 2007. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim. Biophys. Acta 1773:1213-1226.
40. Smith, E. R., et al. 2010. Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells. PLoS One 5:e9295.
41. St-Denis, N. A., and D. W. Litchfield. 2009. Protein kinase CK2 in health and disease: from birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell. Mol. Life Sci. 66:1817-1829.
42. Stura, E. A., and I. A. Wilson. 1991. The streak seeding technique in protein crystallization. J. Cryst. Growth 110:270-282.
43. Tang, X., Y. Zhang, L. Tucker, and B. Ramratnam. 2010. Phosphorylation of the RNase III enzyme Drosha at serine300 or serine302 is required for its nuclear localization. Nucleic Acids Res. 38:6610-6619.
44. Tresini, M., A. Lorenzini, C. Torres, and V. J. Cristofalo. 2007. Modulation of replicative senescence of diploid human cells by nuclear ERK signaling. J. Biol. Chem. 282:4136-4151.
45. Vagin, A. A., and M. N. Isupov. 2001. Spherically averaged phased translation function and its application to the search for molecules and fragments in electron-density maps. Acta Crystallogr. D Biol. Crystallogr. 57:1451- 1456.
46. Waldmann, I., S. Walde, and R. H. Kehlenbach. 2007. Nuclear import of c-Jun is mediated by multiple transport receptors. J. Biol. Chem. 282:27685- 27692.
47. Wolf, I., et al. 2001. Involvement of the activation loop of ERK in the detachment from cytosolic anchoring. J. Biol. Chem. 276:24490-24497.
48. Xu, X., E. Landesman-Bollag, P. L. Channavajhala, and D. C. Seldin. 1999. Murine protein kinase CK2: gene and oncogene. Mol. Cell. Biochem. 191:65-74.
49. Yao, X., X. Chen, C. Cottonham, and L. Xu. 2008. Preferential utilization of Imp7/8 in nuclear import of Smads. J. Biol. Chem. 283:22867-22874.
50. Yao, Z., and R. Seger. 2009. The ERK signaling cascade-views from different subcellular compartments. Biofactors 35:407-416.
51. Yazicioglu, M. N., et al. 2007. Mutations in ERK2 binding sites affect nuclear entry. J. Biol. Chem. 282:28759-28767.
52. Yoon, S., and R. Seger. 2006. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44.
53. Zehorai, E., Z. Yao, A. Plotnikov, and R. Seger. 2010. The subcellular localization of MEK and ERK-a novel nuclear translocation signal (NTS) paves a way to the nucleus. Mol. Cell. Endocrinol. 314:213-220.